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Abstract
As technology continues to develop, external beam radiation therapy is being
employed, with increased conformity, to treat smaller targets. As this occurs, the
dosimetry methods and tools employed to quantify these fields for treatment also
have to evolve to provide increased spatial resolution. The team at the University of
Wollongong has developed a pixelated silicon detector prototype known as the
dose magnifying glass (DMG) for real-time small-field metrology. This device has
been tested in photon fields and IMRT. The purpose of this work was to conduct
the initial performance tests with proton radiation, using beam energies and modula-
tions typically associated with proton radiosurgery. Depth dose and lateral beam
profiles were measured and compared with those collected using a PTW parallel-
plate ionization chamber, a PTW proton-specific dosimetry diode, EBT3 Gafchromic
film, and Monte Carlo simulations. Measurements of the depth dose profile yielded
good agreement when compared with Monte Carlo, diode and ionization chamber.
Bragg peak location was measured accurately by the DMG by scanning along the
depth dose profile, and the relative response of the DMG at the center of modula-
tion was within 2.5% of that for the PTW dosimetry diode for all energy and modu-
lation combinations tested. Real-time beam profile measurements of a 5 mm
127 MeV proton beam also yielded FWHM and FW90 within 1 channel (0.1 mm)
of the Monte Carlo and EBT3 film data across all depths tested. The DMG tested
here proved to be a useful device at measuring depth dose profiles in proton ther-
apy with a stable response across the entire proton spread-out Bragg peak. In addi-
tion, the linear array of small sensitive volumes allowed for accurate point and high
spatial resolution one-dimensional profile measurements of small radiation fields in
real time to be completed with minimal impact from partial volume averaging.
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1 | INTRODUCTION
As imaging techniques continue to evolve, the targets being pre-
sented for treatment in our clinical practice are becoming smaller in
size, oftentimes requiring beams of less than 1.0 cm in diameter for
treatment. This technical challenge is compounded by expanding
treatment sites, including functional radiosurgery, which demand that
small beams be delivered with high precision to high doses. These
small beam sizes require alternative dosimetry methods including
diodes,1,2 micro-ion chambers,3,4 and film5,6 for measuring beam out-
put, as standard radiotherapy ion chamber devices exhibit partial vol-
ume averaging due to their relatively large sensitive volume (SV)
size. Protons have the added complication that their Linear Energy
Transfer or LET varies as a function of depth (or energy), which can
significantly impact detector response. Proton beam scanning and
intensity-modulated proton therapy (IMPT) is another area where
accurate and efficient methods for real-time measurements with high
spatial resolution are necessary. In the case of proton beam scan-
ning, not only is an understanding of the machine output at a speci-
fic point essential to accurate dose delivery, but accurate beam
profile information at various depths in water is also critical for accu-
rate treatment planning and reproducible beam delivery.
For small-field and beam profile measurements, radiochromic film
has often been seen as the standard metrology device, providing high
spatial resolution for such applications. However, in the case of pro-
ton therapy, radiochromic film can exhibit a varying response to
changing LET.6 Additionally, radiochromic film also exhibits a number
of technical and ease-of-use limitations that can limit its deployment
in regular clinical QA programs. Chief of these is that postexposure
processing limits radiochromic film’s ability to provide real-time data.7
In addition, artifacts can be introduced in dose measurements due to
properties of the film itself (e.g., variations in active layer or substrate
thickness, postexposure intensification), environmental and handling
effects (e.g., temperature, light sensitivity), and scanner response (e.g.,
lateral position artifact,8 film orientation,9 dust, fingerprints, film curl,
and local-, inter- and intrascanner factors).7 Finally, inter- and intra-
film lot and scanner variation can result in inconsistent dose mapping
between film lots, scanner models, and environmental processing
conditions.10 Recent improvements in technology and techniques,
such as multiple-channel dosimetry,11 simplified calibration and intra-
lot recalibration,10 calibration-less relative dosimetry,12 and film that
is less sensitive to light have significantly mitigated these concerns.
They have not, however, eliminated them entirely.
In an effort to identify more efficient and real-time methods of
small-field dosimetry, the team at the Center for Medical Radiation
Physics (CMRP) at the University of Wollongong have continued
solid-state development of small pixelated arrays of monolithic sili-
con diode detectors. The prototype device tested in this work is
referred to as the dose magnifying glass (DMG). It is a pixelated sili-
con detector that has the potential to provide not only point dose
measurements with a high degree of spatial resolution, but also
beam profile measurements in real time. However, while this device
has been tested in photon therapy, IMRT, and stereotactic
radiotherapy,13–15 it had yet to be tested in proton therapy. Accord-
ingly, the uniformity of response across the proton spread-out Bragg
peak (SOBP) was unclear.
The goal of this work was to evaluate a DMG prototype in pro-
ton fields typically associated with radiosurgical applications at Loma
Linda University Medical Center (LLUMC). The response of the
device was compared to a commercially available PTW proton diode,
a PTW plane-parallel ionization chamber, and Gafchromic EBT3 film.
Additionally, an in-house developed and validated Geant4-based
Monte Carlo application was used for comparison. Both depth dose
and lateral profiles were evaluated. It was hypothesized that these
tests would not only evaluate the DMG against established forms of
metrology, but also identify future directions for development.
2 | METHODS
The DMG is an array of 128 n+-strips of 2 mm length and 20 lm
width on a p-type silicon substrate 380 lm thick. The pitch (or SV
center-to-center separation) is 100 lm with a p-stop implantation
between the microstrips (80 lm) for compensation of the accumula-
tion layer generated by irradiation of the thick silicon dioxide.13–15
A schematic of the DMG SV array is displayed in Fig. 1. The assem-
bly was pre-irradiated to a dose of 4 MRad with Co-60 before
deployment for testing.
The DMG is glued and wire bonded onto a 400 lm thick kapton
carrier to provide the proper fan out of the signal for connecting the
readout electronics and minimize the impact of these connections on
the proton scatter conditions. The detector is used in passive mode
(no bias applied at the contacts) and readout is carried out with the
detector configured as a planar detector with a common electrode
p+ from the same side as the n+ strips. For this work, the DMG was
mounted to a Lucite probe holder (Fig. 2) for rigidity and to facilitate
mounting in a water tank; however, the compact nature of the
F I G . 1 . Schematic of two n+ SV elements in the DMG detector.
Note the entire DMG is comprised of 128 SV elements.
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device allows for a wide range of mounting options, including within
specialized phantoms and probes.
Figure 3 shows the schematic block diagram of the DMG data
acquisition system. The FPGA motherboard houses a Xilinx
XC3S400 along with a Cypress USB interface to establish the com-
munication with the host computer. The motherboard drives the dig-
ital interface of the TERA06 board, a dual 64 channel preamplifier.
The two TERA06 chips read out the 128 detector channels simulta-
neously.16 Each channel of the TERA06 is a charge-to-frequency
converter equipped with a 16-bit counter that records the number
of times the input charge (accumulated into a capacitor during the
integration time) exceeds the quantum charge, settable by an analog
potentiometer. A digital reset is used for zeroing the counter values
immediately after each frame is acquired. A graphical user interface
(GUI) has been custom designed at the CMRP and provides the
operator with all the controls to acquire the data from the detector
in real time and also perform preprocessing of the raw binary data.
The GUI is compiled under the C++ developer suite Nokia QT
rev4.0. It manages the USB link using dynamic language libraries
(DLL) specifically developed for the USB Cypress interface. It initial-
izes the COM-link, sends the firmware to the FPGA, and acknowl-
edges if the device is connected and fully operational. The operator
controls the acquisition settings and the relevant parameters such as
the integration time, the total acquisition time, and all the comple-
mentary signals necessary for the operation of each TERA06 chip.
The motherboard stores the data into an internal FIFO (First-In First-
Out) and triggers the GUI to download the data in burst-mode.
The size of the burst can be user-defined and optimized based on
the CPU computation load of the host computer to minimize the
USB latency, which varies between 2 and 3 ms. Data losses are
avoided through the use of a dual, cascade FIFO buffer stage of 17
Kbyte of RAM.
Testing of the DMG prototype was conducted in the Gantry 1
treatment room at LLUMC. This treatment room is fitted with a
6-degree-of-freedom robotic patient positioner and associated 2D
orthogonal imaging system17 to aid in alignment of the patient and,
in this case, the experimental setup (Fig. 4). Depth dose and lateral
beam profiles were measured for our standard radiosurgery ener-
gies of 127 MeV (90% dose range in water of 9.88 cm) and
157 MeV (90% dose range in water of 15.15 cm) through a single-
stage scattering system. The single-stage scattering system pro-
vides a maximum field size of 4 cm diameter with collimation pro-
vided via a dedicated radiosurgery cone that attaches to the end of
the proton nozzle.18 This system allows for minimal air gap
between the collimator and the patient, ensuring that the proton
penumbra is minimized while maintaining a high dose rate. Field
sizes measured and presented here were 0.5 and 2.0 cm in diame-
ter, created by brass inserts 7.5 cm in thickness along the beam
axis. An array of beam modulations were tested that are typical for
radiosurgical applications, including an unmodulated case that is
representative of what can be used in functional radiosurgery or
proton beam scanning treatments.
Depth dose and lateral profiles were measured in a water tank
measuring 250 mm 9 250 mm 9 500 mm with a 180 mm diameter
Lexan window 6 mm thick at the upstream surface. Detector motion
was facilitated by a linear corkscrew rail and stepper motor, which
can be orientated either parallel or perpendicular to the beams central
axis. The stepper motor is controlled with a single-axis programmable
controller and micro-step driver with USB 2.0/RS-485/Modbus-RTU
communication, and user interface is achieved via custom designed
LabVIEW 2011 software (National Instruments Corporation, Austin
TX, USA). The DMG was waterproofed for this work through the use
of a custom plastic cover, which also served to make the device light
proof. For comparison with the DMG, depth dose information for the
2 cm diameter beam was also collected with a PTW PR60020 proton
diode and a PTW Markus N23343 plane-parallel ion chamber. These
detectors were selected as the PTW PR60020’s stability of perfor-
mance in proton therapy has been demonstrated previously,1 while
the PTW Markus has been in continued clinical use at our facility for
over 25 years. The PTW Markus N23343 is a plane-parallel ionization
chamber with a SV of 0.055 cm3 vented to air and a 0.03 mm poly-
ethylene entrance window. The device was used with a water-equiva-
lent and water-proof protective cap of 1.06 mm for measurements in
water. The PTW PR60020 proton diode has a single cylindrical SV
with a cross-sectional area of 1 mm2 and a thickness of 20 lm,
located behind a 1.33 mm water-equivalent window.
For beam profile measurements using Gafchromic film, 9 9 5 cm
pieces of Gafchromic EBT3 film (Advanced Materials Group, Wayne,
NJ, USA) were placed in custom designed holders and positioned at
a specified depth within a water tank. Films were irradiated using
unmodulated beams at the same energies (i.e., 127 and 157 MeV),
F I G . 2 . Images of the DMG probe used in this work. The minimal
thickness (lower left) allows for a wide range of mounting options
and minimal perturbation of the proton beam while the linear array
(lower right) allows for concurrent point dose and beam profile
measurements.
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water-equivalent depths (WED), and treatment nozzle configurations
as analogous DMG and MC data. Irradiation duration for film mea-
surements was ~3 or ~3.33 min for 127 and 157 MeV, respectively.
Films were scanned in 48 bit RGB format at 72 dpi using an Epson
10000XL flatbed scanner. Dose maps were created with Film QA
Pro software (Ashland Inc., Wayne, NJ, USA) using a triple-channel
dosimetry method based on a rational function-fit to previously
exposed calibration films.11 Cross-sectional profiles of the dose maps
were obtained using Film QA Pro. Data were normalized based on
the maximum dose value.
At LLUMC, protons are accelerated by a synchrotron and deliv-
ered to treatment rooms in 2.2 s pulses. Thus, the DMG records
signal from impinging protons separated by time intervals where
the device is in a quiescent state. Therefore, before analysis, qui-
escent background time points were separated from data time
points and the average background signal was subtracted from
each data time point. Depth dose profiles were determined using
channels 85–115 (which corresponds to a 3.1 mm width of sensi-
tive area perpendicular to the beam) and normalized to data mea-
sured by the DMG at the shallowest WED for each experimental
case (i.e., 48, 50, or 68 mm WED). Two additional steps were
applied when processing transverse profile data: a calibration step
and removal of over/under-responsive channels. Calibration factors
for each channel were calculated for each energy (i.e., 127 and
157 MeV) at the level of the unmodulated Bragg peak for a 2 cm
diameter proton field. Because the 2 cm beams have a flat profile
over the lateral extent of the DMG, all channels were normalized
to the same constant signal and the corresponding calibration fac-
tors were applied to each channel. Certain channels in the proto-
type device did not produce a signal, or were excessively over/
under-responsive. These later channels (so designated if the abso-
lute value of their signal had a percent difference greater than
50% when compared to the average of four neighboring nonzero
channels) were replaced with zero signal. Transverse dose profiles
were normalized with respect to the profile centroid.
Monte Carlo simulations provided further comparative data for
both depth dose and lateral profiles. These simulations were per-
formed using software developed in-house that incorporates the
Geant4 toolkit.19,20 Protons and secondary particles were tracked
through a model of our Gantry 1 treatment nozzle21,22 using a
custom physics list incorporating: low energy Livermore physics
models for electromagnetic interactions, binary cascade models of
inelastic interactions of hadrons and heavy ions, and the high-pre-
cision neutron package.23 The treatment nozzle configuration and
proton energies were chosen to mimic the experimental conditions
described above (Fig. 5). In particular, simulated 127 or 157 MeV
protons were delivered through a single-stage scattering system to
F I G . 3 . DMG data acquisition architecture.
F I G . 4 . DMG experimental setup for depth dose and beam profile
measurements with a magnified view (bottom). Note the extended
X-ray imager (top) which is used to ensure detector alignment and
parallel travel with the beam central axis.
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a voxelized water phantom. The beams were either unmodulated,
or modulated to 15, 30 or 60 mm. Total dose was scored in each
voxel, and depth dose and transverse profiles were calculated
using software developed in Python. Depth dose profiles for
20 mm diameter beams were determined using voxels of
1.0 9 1.0 9 1.0 mm, phantom range cuts of 250 lm, and 1.3 bil-
lion particle histories per simulation. Modulated depth profiles
were normalized with respect to dose at the center of modulation
(COM) of the spread-out Bragg peak, and unmodulated depth
dose profiles were normalized by maximum dose. Depth dose pro-
files were determined using the central array of 2 9 2 9 1 voxels
column of voxels (thus presenting a sensitive area of
2 9 2 9 1 mm3 for depth dose analysis). Transverse dose profiles
of 5 mm diameter beams were determined using voxels of the
same size as the active element of the DMG (X 9 Y 9 Z dimen-
sions of 0.02 9 2.0 9 0.38 mm with a center-to-center element
spacing of 0.1 mm) with range cuts of 100 lm and 5.1 billion his-
tories. Transverse profiles were normalized with respect to maxi-
mum dose.
3 | RESULTS
The DMG can be operated as a simple dosimeter, with charge mea-
sured over either a single SV or multiple SV’s across a given linear
displacement. The single SV option allows for point measurements
of a high spatial resolution (2 mm long and 20 lm wide) to be made,
which is of significant benefit in very small or high-gradient radiation
fields. The disadvantage of this mode of operation is that the small
SV requires longer acquisition times to accrue sufficient statistics. It
is envisaged that the DMG would be operated more typically as a
single array of SV’s which all individually contribute charge-to-detec-
tor response at a given location. The number of SV’s analyzed is cus-
tomizable and provides the user greatest flexibility with selecting a
total SV size suitable for the field size under study. This later mode
was chosen to evaluate the DMG performance in measuring the
depth dose profiles of a passively scattered proton beam (Figs. 6
and 7). Thirty DMG SV elements were used at each measurement
depth (corresponding to a total SV length of 3.1 mm perpendicular
to the beam) of a 127 MeV or 157 MeV 20 mm diameter proton
beam, for comparison with a commercial PTW diode, PTW Markus
parallel-plate ionization chamber and Monte Carlo.
For unmodulated proton beams, the proximal edge of the Bragg
peak and the peak location was measured accurately by the DMG.
Modulated data measured by the DMG exhibited good agreement to
the PTW diode and Markus chamber, especially across the SOBP.
Across the plateau region of the SOBP, the DMG exhibited an aver-
age response within 1% of the PTW diode, for all cases studied
except 157 MeV with a 60 mm modulation. For the 157 MeV
60 mm modulation case, the shape of the SOBP was well repre-
sented by the DMG, however the DMG did over-respond in the
SOBP region by an average of 3.3% when compared to the PTW
proton diode and an average of 1.4% when compared with the PTW
Markus plane-parallel ion chamber.
As all depth dose data were normalized at the depth of shallow-
est DMG measurement, analyzing the COM response of each detec-
tor type relative to a commercially available small SV solid-state
detector (PTW diode) with a demonstrated stability in proton
therapy,1 provides an indication of detector stability in this variable
LET region. These data, displayed in Table 1, demonstrated that the
relative response of the DMG at the COM was within 2.5% of a
PTW diode detector for all energy and modulation combinations
F I G . 5 . Schematic diagram of the simulated geometry of the Gantry 1 treatment nozzle with radiosurgery cone geometry used in Geant4
Monte Carlo simulations. The components are: the secondary emission monitor (SEM) and titanium exit window, multiwire ion chamber
(MWIC), initial scatterer (two lead wedges) (S1), first proton transmission ionization chamber (pTIC1), first steel fixed aperture (FA1), second
pTIC2, second fixed aperture (FA2), Perspex modulation wheel, third fixed aperture (FA3), multielement transmission ion chamber (MTIC), brass
precollimator (PCOL), precollimator and ridge filter (RFIL), radiosurgery cone (RSC), and water phantom.
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F I G . 6 . Measured and simulated depth dose profiles for varying beam modulations in water for a 127 MeV, 20 mm diameter proton beam.
F I G . 7 . Measured and simulated depth dose profiles for varying beam modulations in water for a 157 MeV, 20 mm diameter proton beam.
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tested. Additionally, the DMG data do not show a decrease in
response over the SOBP region and the shape of the SOBP com-
pares well with the other detector modalities. Both of these features
indicate an LET independence of this device for clinical proton ther-
apy energies, albeit additional measurements may be necessary with
discrete proton energies to validate this.
In routine QA applications, it is expected that the DMG will be
operated using all SV elements to gain both point dose measure-
ment data as well as beam profile data. Data were collected for
5 mm diameter, 127 and 157 MeV proton beams at various depths
along the depth dose profile (Figs. 8 and 9). Excellent agreement in
profile shape was observed for all measurement locations when
compared with Monte Carlo and EBT3 film data. Note that the edge
of the detector array is at a displacement of 1.6 mm and 1.7 mm
for the 127 MeV and 157 MeV cases respectively, so no data are
available below these displacements. For 127 MeV, the FWHM and
FW90 reported by the DMG was within 1 channel (0.1 mm) of
the Monte Carlo and EBT3 film data across all depths tested. The
157 MeV data exhibited additional statistical uncertainty in the
measurement leading to the suppression of additional channels (see
Method) across the measured profile. These suppressed channels
are clearly visible as null channels in Figs. 8 and 9. Between dis-
placements of 2 mm and 11 mm, there was on average eight sup-
pressed channels for the 127 MeV case while for 157 MeV profiles
the number of suppressed channels increased to 14. While the addi-
tional null channels for the 157 MeV case do impact the total data
acquired, it did not impact agreement of the overall beam profile
shape as the FWHM and FW90 were measured by the DMG to
within 2 channels (0.2 mm) of the Monte Carlo and EBT3 film
data for all depths tested.
4 | DISCUSSION
The beam profiles measured with the DMG showed excellent agree-
ment with Monte Carlo and Gafchromic film data. The high spatial
resolution of the device is comparable to that of film and allows for
measurement of the smallest fields currently used in clinical proton
therapy (e.g., 5 mm diameter). Unlike film, that requires postprocess-
ing and special handling, the DMG provides readout that is refreshed
in real time via a graphical user interface. The real-time nature of the
data acquisition is very useful, especially for proton pencil beam scan-
ning applications, where efficient real-time feedback to accelerator
staff is important during the acceptance testing and commissioning
process. When comparing with other data sets or if further analysis is
required, the data can be output for graphing and analysis using any
of the common computer-based tools for this purpose.
The DMG tested in this project is a prototype instrument and
certain refinements are necessary prior to clinical deployment in pro-
ton therapy. Firstly, several channels were removed from analysis
because they either were unresponsive or produced excessively high
amounts of electronic noise that could not be corrected for. Such
channels may be caused by issues in the manufacturing process and
may be exacerbated by sensitive cabling and connections. The loss
of data can impact measured results and lead to the generation of
an incomplete data set, however, in this study the suppression of
these channels in our prototype did not significantly impact the
beam profile agreement with either Monte Carlo or EBT3 film. In
addition, for production DMG detectors, scanning laser systems such
as those used in high energy physics24 could be used to evaluate the
DMG systems prior to deployment allowing for selection of units
that have all of their SV elements operating within acceptable limits.
Beam profile measurements for 157 MeV protons exhibited
increased noise and statistical uncertainty, which can be traced to
the cabling system in this existing prototype. The aluminized ribbon
cables between the DMG probe and the DAQ system proved to be
very delicate and underwent degradation as the experiments pro-
gressed. The ruggedness of this component will have to be
addressed as we move toward a clinical system.
When applying a detector system to scanned proton therapy,
the detector’s ability to handle high instantaneous dose rates needs
to be considered. In this study, the DMG was tested in a pulsed pro-
ton therapy environment provided by a synchrotron with a 0.4 s
pulse duration and a 2.2 s duty cycle.25 Average dose rates of up to
12 Gy/min, corresponding to an instantaneous dose rate of 66 Gy/
min, were tested with stable results. Above this value, some under
response of up to 10% was observed for average dose rates of
TAB L E 1 Relative dose measured by each modality at the COM for
varying beam energy and modulation combinations. The difference
(as a percentage) of each modality is calculated relative to the
response of the PTW Diode and represented as a percentage
(Difference = 100 9 (Dx-Ddiode)/Ddiode).
Relative dose at COM
Difference
wrt PTW Diode (%)
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60 Gy/min. While these dose rates are rarely seen in passively deliv-
ered clinical proton therapy applications, they can be encountered in
proton beam scanning applications. Additionally, as the trend of radi-
ation treatment has been toward higher dose rates and faster treat-
ments, especially when applied to SRS and SBRT treatments, it can
be foreseen that a uniform response at higher dose rates would fur-
ther widen the clinical application of the DMG. An improvement in
this regard is already under investigation, as we believe that uniform
response with dose rates exceeding 12 Gy/min (average) may be
achieved by reducing the integration time of the system. By doing
so, it is hypothesized that counts will not be missed when the col-
lected charge is too high (i.e., in a high dose-rate environment).
The DMG prototype provided a small linear array of
2000 lm 9 20 lm 9 380 lm SV’s for measurement of beam profile
data and dose with high spatial resolution. The ability to measure
both parameters at a given depth or for a given experimental setup
in air is certainly more efficient than using a scanned single volume
detector or film which requires postprocessing and does not provide
information in real time. The high spatial resolution and small SV size
of the DMG does mean that data acquisition times are longer,
requiring 5–10 Gy per measurement to achieve adequate statistics.
However, extended data acquisition times for small SV detectors is a
suitable tradeoff given the spatial resolution enhancements they pro-
vide. Further reduction of the SV size below 2000 lm in one dimen-
sion would improve the spatial resolution of the device and reduce
any impact of partial volume averaging for very small fields, although
this would be at the cost of data acquisition times.
The size of the DMG array and the one-dimensional nature limit
the clinical applications to very small proton fields if beam profile mea-
surements are required. Increasing the size of the array would widen
its application to larger passively scattered proton fields and also to
lower energies in proton pencil beam scanning applications, which typ-
ically have wider beam spots and longer low dose tails. The addition of
either a second orthogonal array of SV’s or a complete 2D array of
SV’s would also allow for concurrent measurement of point dose and
orthogonal beam profiles (or the entire beam profile in the case of a
F I G . 8 . Measured beam profiles at varying depths in water for a 127 MeV proton beam. Geant4 simulation data are also provided for
comparison. A simulated central beam axis depth dose profile utilizing 0.25 9 0.25 9 0.25 mm3 voxels with DMG measurement locations
marked is provided for reference (top).
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2D array), which would provide further QA information in pencil beam
scanning applications where the size and shape of the proton beam
also need to be evaluated. The feasibility of this approach was recently
demonstrated by the CMRP in development, characterization, and
application of a 2D monolithic silicon pixel array (with submillimeter
SVs and a pitch of 2 mm) in dose mapping on a medical linac.26,27
The DMG tested here has demonstrated that it can be used to pro-
vide real-time measurements of both point dose and beam profiles of
pencil proton beams with up to 0.02 mm resolution. Such resolution is
key in obtaining a precise picture of the sharp dose gradients when the
detector is properly orientated with the radiation field. This informa-
tion, while very useful for collimated beams used in proton radiosurgery
and functional radiosurgery, is also especially useful in pencil beam
scanning applications for both commissioning and routine QA. During
the commissioning process, the collection of accurate beam profile data
as a function of depth in water for the complete clinical range of proton
energies is essential for evaluation of system performance/stability and
also for input to the treatment planning system (or validation of a
Monte Carlo system which generates data for the treatment planning
system).28 Such measurements are typically completed using radiochro-
mic film and/or scanned ion chamber detectors;28,29 however, a pixe-
lated silicon detector such as the DMG may provide a means for
measuring these profiles in real time with greater efficiency as profile
data can be measured at each depth without the need for lateral detec-
tor scanning. Additionally, for daily QA of pencil beam proton systems,
many centers use ion chamber arrays such as the I’mRT MatriXX (IBA
Dosimetry, Schwarzenbruck, Germany) which is comprised of a 2D
array of 32 9 32 ion chambers with a center-to-center spacing of
7.6 mm and a SV size of 4 mm diameter and 5 mm height. The DMG
may help augment these systems, especially if it can be developed as a
nozzle-mounted 2D pixelated transmission sensor system.30 The
improved spatial resolution of the DMG would allow for more accurate
daily analysis of the proton beam size and shape for evaluation of accel-
erator/beam transport performance.
F I G . 9 . Measured and simulated beam profiles at varying depths in water for a 157 MeV proton beam. Geant4 simulation data are also
provided for comparison. A simulated central beam axis depth dose profile utilizing 0.25 9 0.25 9 0.25 mm3 voxels with DMG measurement
locations marked is provided for reference (top).
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The DMG prototype tested here proved to be a useful device at
measuring depth dose profiles in proton therapy, with negligible vari-
ation in response across the clinical proton SOBP. In addition, the
small SV allowed for accurate point measurements of small radiation
fields to be completed without the partial volume averaging exhibited
by larger ion chamber detectors. The device’s high spatial resolution
and linear SV arrangement also allowed for beam profiles to be mea-
sured concurrently with depth dose measurements in real time. The
dual function of this device lends itself to QA measurements in
small-field proton radiosurgery and also to beam commissioning in
proton beam scanning, where accurate and efficient measurements
of the pencil beam profiles as a function of depth are of paramount
importance to intensity-modulated proton therapy treatment plan-
ning. The application of 2D silicon pixel transmission arrays based on
this technology, and already developed by the CMRP, could be the
next step in real-time QA and commissioning in proton therapy.
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